Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRSN | BMY | AMGN | GILD | MRNA |
| Company | Mersana Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.73 | 48.45 | 266.83 | 67.80 | 102.08 |
| High | 3.81 | 48.60 | 267.51 | 67.89 | 106.42 |
| Low | 3.71 | 48.24 | 263.81 | 67.19 | 101.30 |
| Last | 3.78 | 48.38 | 265.61 | 67.33 | 104.31 |
| Change | -0.01 | -0.13 | +0.10 | -0.42 | +0.45 |
| % Change | -0.26% | -0.27% | +0.04% | -0.62% | +0.43% |
| Volume | 376,700 | 8,679,097 | 1,240,657 | 3,000,590 | 1,532,356 |
| 20-Day Average Volume | 1,629,188 | 11,358,466 | 2,226,703 | 6,322,731 | 3,342,953 |
| Previous Close | 3.79 | 48.51 | 265.51 | 67.75 | 103.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.28 | 51.37 | 273.85 | 70.94 | 105.63 |
| 20-Day Raw Stochastic | 6.99% | 5.11% | 5.67% | 4.09% | 40.23% |
| 20-Day Relative Strength | 40.84% | 36.70% | 38.56% | 31.01% | 51.70% |
| Weighted Alpha | +90.65 | -29.87 | +5.69 | -23.19 | -16.91 |
| Today's Opinion | 40% Buy | 56% Sell | 40% Sell | 100% Sell | 72% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 40% Sell | 100% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.80% since 04/09/24 | -6.11% since 04/09/24 | -1.85% since 04/09/24 | -3.52% since 04/09/24 | -6.27% since 04/09/24 |
| Low | 3.68 on 04/12/24 | 48.12 on 04/15/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 101.46 on 04/16/24 |
| High | 3.96 on 04/15/24 | 51.28 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 110.29 on 04/10/24 |
| 1-Month | |||||
| %Chg | -25.00% since 03/15/24 | -7.44% since 03/15/24 | -1.31% since 03/15/24 | -8.43% since 03/15/24 | +0.72% since 03/15/24 |
| Low | 3.68 on 04/12/24 | 48.12 on 04/15/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 97.00 on 04/03/24 |
| High | 5.11 on 03/21/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +39.48% since 01/16/24 | -3.11% since 01/16/24 | -12.56% since 01/16/24 | -21.53% since 01/16/24 | +2.39% since 01/16/24 |
| Low | 2.52 on 01/19/24 | 47.58 on 02/06/24 | 263.95 on 04/16/24 | 67.18 on 04/16/24 | 84.06 on 02/13/24 |
| High | 6.28 on 03/11/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +127.71% since 10/16/23 | -15.26% since 10/16/23 | -7.50% since 10/16/23 | -14.80% since 10/16/23 | +13.77% since 10/16/23 |
| Low | 1.07 on 10/31/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 62.55 on 11/02/23 |
| High | 6.28 on 03/11/24 | 57.65 on 10/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 459,738 | 98,318,080 | 142,291,856 | 84,353,968 | 39,765,916 |
| Shares Outstanding, K | 121,303 | 2,026,759 | 535,919 | 1,245,077 | 382,880 |
| Annual Sales | 36,860,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -171,670,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 10,700,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -19,540,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 1.50 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/28/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.44 | 14.33 | 10.13 | 0.00 |